General Practitioners Research Institute
Rationale: Spirometry is essential in the diagnosis of airway disease and can be useful in monitoring patients. Despite the essential role, spirometry remains largely underused in primary care. Due to Coronavirus disease (COVID-19), the use of office spirometry is contraindicated in many countries. Furthermore, spirometric devices are costly and personnel requires special training. Referral for spirometry increases the cost for patients and lowers the feasibility. Part of the reason for underdiagnosis of airway disease are the specific situations (such as exercise-induced asthma) in which spirometry in office setting might not reveal abnormalities. In recent years, handheld spirometry linked to phones/apps has been developed for study purposes and remote monitoring. Objective: To study the feasibility, quality and added value of at-home spirometry for the diagnosis and monitoring of asthma and Chronic Obstructive Pulmonary Disease (COPD) in primary care.
COPD Asthma
NuvoAir platform
| Study Type : | OBSERVATIONAL |
| Estimated Enrollment : | 144 participants |
| Official Title : | Home Spirometry for the Diagnosis and Monitoring of Asthma and COPD in Primary Care in The Netherlands and Sweden: an Implementation Study |
| Actual Study Start Date : | 2021-09-27 |
| Estimated Primary Completion Date : | 2022-12-28 |
| Estimated Study Completion Date : | 2022-12-28 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 16 Years |
| Sexes Eligible for Study: | ALL |
| Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
Gpri
Groningen, Netherlands, 9713 g
Not yet recruiting
Karolinska Institute
Solna, Stockholm, Sweden,